As the full moon marked the Mid-Autumn Festival, employees remained dedicated to their duties. During the 2026 Mid-Autumn Festival, Song Lai, Chairman of LINUO Pharmaceutical Packaging Group, visited production workshops to learn about production and operations, quality control, safety management, and R&D efforts, and extended holiday greetings to researchers, frontline workers, and staff on duty throughout the holiday.
From specialty glass production to pharmaceutical packaging manufacturing, and from high-end sterile packaging materials to glass substrates for advanced AI chip packaging, Song Lai visited operational sites and spoke with employees, focusing on production organization, product quality, technological R&D, and project progress. He encouraged everyone to remain committed to their roles, pursue continuous improvement, and integrate safety, quality, and efficiency throughout production and operations, accelerating the transformation of innovation into product advantages and industrial capabilities.
That evening, Song Lai joined frontline employees for dinner to celebrate the Mid-Autumn Festival, extending holiday wishes to them and their families and thanking them for their contributions to the company’s development. He noted that their dedication during the holiday ensured smooth and orderly production and operations, reflecting the responsibility and commitment of LINUO employees to industrial development and collaborative progress.
LINUO Pharmaceutical Packaging is currently advancing its “1+3” strategy, guided by an industry-centered approach, strategic direction, innovation, and AI empowerment. The company is strengthening its two core businesses—pharmaceutical packaging and heat-resistant glass—while focusing on two strategic directions: life sciences and high-end glass materials. The life sciences business is accelerating its development of RTU and PFS high-end sterile pharmaceutical packaging, continuously enhancing its technology, quality systems, and international capabilities. Building on its expertise in specialty glass, the Technology Innovation Incubation Center is focusing on new materials such as glass substrates for advanced AI chip packaging, accelerating R&D breakthroughs and industrial implementation. At the same time, the company is advancing digital and intelligent manufacturing toward AI-enabled manufacturing across all operational scenarios, improving product quality, production efficiency, and global delivery capabilities.
The value of strategy must ultimately be measured by operating results. The company will translate its strategic priorities into operational targets, key projects, and accountable organizational units, strengthen budget management and analysis of investment inputs and returns, and focus on order delivery, quality improvement, cost efficiency, and cash flow management. It will promote business portfolio optimization, the transition to new growth drivers, and improvements in operational quality and efficiency, serving customers with reliable products and solutions and rewarding investors through sound operating performance. These efforts will align corporate development, customer value, and long-term shareholder returns, strengthening the foundation for high-quality development.
A tribute to every LINUO employee who remained at their post during the Mid-Autumn Festival!
FAQ
What did Chairman Song Lai review during the visit?
He reviewed production and operations, quality control, safety management, R&D and project progress, while extending holiday greetings to employees working during the Mid-Autumn Festival.
What are LINUO’s key business and innovation priorities?
LINUO is strengthening its pharmaceutical packaging and heat-resistant glass businesses while advancing high-end sterile RTU and PFS packaging and research into glass substrates for advanced AI chip packaging.
How is LINUO translating its strategy into operational priorities?
The company is focusing on order delivery, quality improvement, cost efficiency and cash flow management, supported by budget management, investment analysis and clearly assigned project responsibilities.
October 20, 2026 
